Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | XBP1 | P17861 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.38 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | TERT | O14746 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29410309 | 0.71 | MAPT (0.43) | MAPTRAB9ANPC1XBP1HTT | |
| SCHEMBL9242953 | 0.71 | MAPT (0.43) | MAPTRAB9ANPC1XBP1HTT | |
| SCHEMBL8631899 | 0.71 | MAPT (0.43) | MAPTRAB9ANPC1XBP1HTT | |
| SCHEMBL9240777 | 0.71 | MAPT (0.43) | MAPTRAB9ANPC1XBP1HTT | |
| SCHEMBL8629540 | 0.71 | MAPT (0.43) | MAPTRAB9ANPC1XBP1HTT | |
| SCHEMBL8629536 | 0.71 | MAPT (0.43) | MAPTRAB9ANPC1XBP1HTT | |
| SCHEMBL21563384 | 0.71 | CYP19A1 (0.40) | MAPTRAB9ANPC1HTTPTGS2 | |
| SCHEMBL31238361 | 0.69 | MAPT (0.51) | MAPTRAB9ANPC1XBP1HTT | |
| SCHEMBL12620335 | 0.68 | NLRP3 (0.42) | MAPTRAB9ANPC1XBP1HTT | |
| Graveolide SCHEMBL31279270 | 0.66 | PTGS2 (0.59) | MAPTRAB9ANPC1XBP1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240224882-A1 | LIGHT SOURCE | SEOUL VIOSYS CO LTD (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240224882-A1 | LIGHT SOURCE | SEOUL VIOSYS CO LTD (KR) | 2024-07-11 | — | — | US | disclosed |
| US-11778953-B2 | Light source for plant cultivation | SEOUL VIOSYS CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11778953-B2 | Light source for plant cultivation | SEOUL VIOSYS CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-20220192103-A1 | LIGHT SOURCE FOR PLANT CULTIVATION | SEOUL VIOSYS CO., LTD. (KR) | 2022-06-23 | — | — | US | disclosed |
| US-20210332062-A1 | HETERO-SUBSTITUTED CYCLIC LACTONE ANALOGUES AND USES THEREOF | BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2021-10-28 | — | — | US | disclosed |
| EP-3841869-A1 | LIGHT SOURCE FOR PLANT CULTIVATION | Seoul Viosys Co., Ltd. (KR) | 2021-06-30 | — | — | EP | disclosed |
| US-11021488-B2 | Hetero-substituted cyclic lactone analogues and uses thereof | BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2021-06-01 | — | — | US | disclosed |
| US-20200060099-A1 | LIGHT SOURCE FOR PLANT CULTIVATION | SEOUL VIOSYS CO., LTD. (KR) | 2020-02-27 | — | — | US | disclosed |
| US-20190345167-A1 | HETERO-SUBSTITUTED CYCLIC LACTONE ANALOGUES AND USES THEREOF | BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2019-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190345167-A1 | HETERO-SUBSTITUTED CYCLIC LACTONE ANALOGUES AND USES THEREOF | MCL1, BCL9L, DLD | MAPT 4878/4885RAB9A 2722/4885NPC1 4023/4885 |
| US-11021488-B2 | Hetero-substituted cyclic lactone analogues and uses thereof | MCL1, BCL9L, DLD | MAPT 4878/4885RAB9A 2722/4885NPC1 4023/4885 |
| US-20210332062-A1 | HETERO-SUBSTITUTED CYCLIC LACTONE ANALOGUES AND USES THEREOF | MCL1, BCL9L, DLD | MAPT 4878/4885RAB9A 2722/4885NPC1 4023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.